Charles Zhou Stock Analyst Profile - Guggenheim Research Coverage - Stocknear

Charles Zhou

Stock Analyst at Guggenheim

(3.54)
# 2649
Out of 5,506 analysts
14
Total ratings
Success rate
Average return

8 Stocks

Name Action PT Current % Upside Ratings Updated
COGT Cogent Biosciences
Maintains: Strong Buy
17 20
15.76 26.9% 2 Aug 25, 2025
FUTU Futu Hldgs
Maintains: Strong Buy
130 136
169.98 -19.99% 3 Mar 17, 2025
ZYME Zymeworks
Reiterates: Buy
16
16.94 -5.55% 1 Mar 8, 2023
MGNX Macrogenics
Downgrades: Neutral
n/a
n/a n/a 1 May 5, 2022
PMVP PMV Pharma
Initiates Coverage On: Buy
56
1.44 3788.89% 1 Aug 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
1.8 2455.56% 1 Jun 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 3 Aug 25, 2017